{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:20Z","timestamp":1792788980390,"version":"4.5.0"},"reference-count":82,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Regional Development Fund","award":["ITMS2014+: 313011W410"],"award-info":[{"award-number":["ITMS2014+: 313011W410"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Osteonecrosis of the jaw (ONJ), including the maxilla and mandible, is considered a challenging therapeutic problem, mainly due to the lack of understanding of its pathogenesis. It is well known that ONJ is a severe side effect caused by certain medications used to treat bone metastasis and osteoporosis, such as bisphosphonates, which inhibit bone resorption. Other therapeutics with similar side effects are, for instance, receptor activators of nuclear factor kappa-B ligand (RANK-L) inhibitor (denosumab), tyrosine kinase inhibitors (sunitinib), and antiangiogenics (bevacizumab). The conservative or surgical treatment of these medication-related osteonecroses of the jaw (MRONJs) is generally effortful and still not entirely effective. Therefore, the research seeks alternative treatment options like tissue engineering and stem cell therapy, which predominantly represent mesenchymal stem cells (MSCs) and their derivatives, such as extracellular vesicles. Moreover, it was published that novel stem cell therapy could even prevent the onset of MRONJ. On the other hand, the administration of stem cells may also be accompanied by some other health risks, such as an increased chance of cancer metastasis occurrence in cancer patients. The current review paper summarizes the most recent progress in stem-cell-based and stem-cell-free treatment options for the ONJ. Similarly, we discuss this novel approach\u2019s future perspectives and possible obstacles.<\/jats:p>","DOI":"10.3390\/biom15040595","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:48:46Z","timestamp":1744850926000},"page":"595","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent Stem-Cell-Based and Stem-Cell-Free Possibilities for the Therapeutic Management of the Osteonecrosis of the Jaw"],"prefix":"10.3390","volume":"15","author":[{"given":"Merita","family":"Mazreku","sequence":"first","affiliation":[{"name":"Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5074-9621","authenticated-orcid":false,"given":"L\u2019ubo\u0161","family":"Dani\u0161ovi\u010d","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7145-7206","authenticated-orcid":false,"given":"Martin","family":"Klein","sequence":"additional","affiliation":[{"name":"Institute of Histology and Embryology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Kleinov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Histology and Embryology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lon\u010dar Brzak, B., Horvat Aleksijevi\u0107, L., Vindi\u0161, E., Kordi\u0107, I., Grani\u0107, M., Juras, D.V., and Rogulj, A.A. (2023). Osteonecrosis of the Jaw. Dent. J., 11.","DOI":"10.3390\/dj11010023"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e10785","DOI":"10.1002\/jbm4.10785","article-title":"Pathophysiology of Medication-Related Osteonecrosis of the Jaw\u2014A Minireview","volume":"7","author":"Tetradis","year":"2023","journal-title":"JBMR Plus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jds.2022.03.014","article-title":"Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study","volume":"17","author":"Seki","year":"2022","journal-title":"J. Dent. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bjoms.2020.03.022","article-title":"Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ)","volume":"58","author":"Pichardo","year":"2020","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s00784-021-04261-4","article-title":"Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab","volume":"26","author":"Wick","year":"2022","journal-title":"Clin. Oral Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e23500","DOI":"10.1002\/dvg.23500","article-title":"Medication-related osteonecrosis of the jaw: A literature review and update","volume":"60","author":"Kuroshima","year":"2022","journal-title":"Genesis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.24.00171","article-title":"Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Breast Cancer During a 20-Year Follow-Up: A Population-Based Multicenter Retrospective Study","volume":"43","author":"Brunner","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101931","DOI":"10.1016\/j.jormas.2024.101931","article-title":"Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study","volume":"125","author":"Boffano","year":"2024","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/1566524023362104","article-title":"Bisphosphonate mechanism of action","volume":"2","author":"Rodan","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: Mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/bcp.14681","article-title":"Medication-related osteonecrosis of the jaw: Analysing the range of implicated drugs from the Australian database of adverse event notifications","volume":"87","author":"Teoh","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e76207","DOI":"10.7554\/eLife.76207","article-title":"Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate","volume":"11","author":"Okawa","year":"2022","journal-title":"eLife"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Elsayed, R., El-Awady, A., Cutler, C., Kurago, Z., Elashiry, M., Sun, C., Bloomquist, R., Meghil, M.M., and Elsalanty, M.E. (2021). Matrix-Bound Zolzoledronate Enhances the Biofilm Colonization of Hydroxyapatite: Effects on Osteonecrosis. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111380"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1750-1172-7-S1-S6","article-title":"Cherubism: Best clinical practice","volume":"7","author":"Papadaki","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000510002","article-title":"Hyperparathyroidism-Jaw Tumor Syndrome","volume":"14","author":"Weaver","year":"2021","journal-title":"Case Rep. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8768162","DOI":"10.1155\/2016\/8768162","article-title":"Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches","volume":"2016","author":"Lombard","year":"2016","journal-title":"Stem Cells Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1096\/fj.201901819RR","article-title":"Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw","volume":"34","author":"Elsayed","year":"2020","journal-title":"FASEB J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kuehn, S., Scariot, R., and Elsalanty, M. (2023). Medication-Related Osteonecrosis: Why the Jawbone?. Dent. J., 11.","DOI":"10.3390\/dj11050109"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Roato, I., Mauceri, R., Notaro, V., Genova, T., Fusco, V., and Mussano, F. (2023). Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24097948"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/00220345241258990","article-title":"Macrophage Polarization during MRONJ Development in Mice","volume":"103","author":"Soundia","year":"2024","journal-title":"J. Dent. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20002","DOI":"10.18632\/oncotarget.4755","article-title":"Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation","volume":"6","author":"Tseng","year":"2015","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wat, W.Z.M. (2016). Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw. Dent. J., 4.","DOI":"10.3390\/dj4040038"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.sdentj.2022.01.003","article-title":"Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies","volume":"34","author":"AlRowis","year":"2022","journal-title":"Saudi Dent. J."},{"key":"ref_26","first-page":"2662","article-title":"Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review","volume":"25","author":"Goker","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00198-021-06078-z","article-title":"Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis","volume":"32","author":"Ferreira","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcms.2024.01.007","article-title":"The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review","volume":"52","author":"Nowak","year":"2024","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/SCS.0000000000006976","article-title":"The Role of Autologous Platelet Concentrates in the Treatment of Medication-Related Osteonecrosis of the Jaw","volume":"32","author":"Ye","year":"2021","journal-title":"J. Craniofac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sacco, R., Akintola, O., Sacco, N., Acocella, A., Calasans-Maia, M.D., Maranzano, M., and Olate, S. (2023). The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature. Medicina, 59.","DOI":"10.3390\/medicina59050968"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10006-020-00831-0","article-title":"Laser surgery in management of medication-related osteonecrosis of the jaws: A meta-analysis","volume":"24","author":"Momesso","year":"2020","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bjoms.2019.12.001","article-title":"Effectiveness of laser-assisted treatments for medication-related osteonecrosis of the jaw: A systematic review","volume":"58","author":"Li","year":"2020","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Frutuoso, F., Freitas, F., Vilares, M., Francisco, H., Marques, D., Caram\u00eas, J., and Moreira, A. (2024). Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series. Diseases, 12.","DOI":"10.3390\/diseases12090205"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bouland, C.L., Javadian, R., Gilis, S., Yanni, A., Le Clercq, M., Mestrallet, P., Kampouridis, S., Bron, D., Lalmand, M., and Vanden Eynden, X. (2024). Treatment of medication-related osteonecrosis of the jaw with cell therapy. Front Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1338376"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5125\/jkaoms.2021.47.2.65","article-title":"Mesenchymal stem cells in the treatment of osteonecrosis of the jaw","volume":"47","year":"2021","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1021\/acsbiomaterials.8b01468","article-title":"Microfiber-Reinforced Composite Hydrogels Loaded with Rat Adipose-Derived Stem Cells and BMP-2 for the Treatment of Medication-Related Osteonecrosis of the Jaw in a Rat Model","volume":"5","author":"Ning","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.actbio.2016.06.022","article-title":"Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model","volume":"42","author":"Kaibuchi","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.jds.2024.05.003","article-title":"Prevention of medication-related osteonecrosis of the jaw in mice by adipose-derived stem cells associated with activated autophagic flux","volume":"19","author":"Dong","year":"2024","journal-title":"J. Dent. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13287-019-1277-y","article-title":"Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor \u03b2-1-mediated gingival wound healing","volume":"10","author":"Zang","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1089\/scd.2012.0615","article-title":"Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine","volume":"22","author":"Li","year":"2013","journal-title":"Stem Cells Dev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jcms.2015.04.026","article-title":"Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model","volume":"43","author":"Abarrategi","year":"2015","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jbmr.3292","article-title":"Transplantation of Noncultured Stromal Vascular Fraction Cells of Adipose Tissue Ameliorates Osteonecrosis of the Jaw-Like Lesions in Mice","volume":"33","author":"Kuroshima","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_44","first-page":"e529","article-title":"Bisphosphonate-related osteonecrosis. Application of adipose-derived stem cells in an experimental murine model","volume":"24","year":"2019","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Lozano, F.J., O\u00f1ate-S\u00e1nchez, R., Gonz\u00e1lvez-Garc\u00eda, M., Vall\u00e9s-Bergad\u00e1, M., Mart\u00ednez, C.M., Revilla-Nuin, B., Guerrero-Giron\u00e9s, J., Moraleda, J.M., and Garc\u00eda-Bernal, D. (2020). Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Tooth Extractions Sites Ameliorates the Incidence of Osteonecrotic Jaw-Like Lesions in Zoledronic Acid-Treated Rats. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061649"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10266-024-00900-w","article-title":"Application of mesenchymal stromal cell sheets to prevent medication-related osteonecrosis of the jaw with titanium implants in rats","volume":"112","author":"Nishimaki","year":"2024","journal-title":"Odontology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Liu, X., Liu, C., Lin, Q., Shi, T., and Liu, G. (2024). Exosome-loaded hydrogels for craniofacial bone tissue regeneration. Biomed. Mater., 19.","DOI":"10.1088\/1748-605X\/ad525c"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zou, J., Yang, W., Cui, W., Li, C., Ma, C., Ji, X., Hong, J., Qu, Z., Chen, J., and Liu, A. (2023). Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon-bone healing. J. Nanobiotechnology, 21.","DOI":"10.1186\/s12951-023-01778-6"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/ten.teb.2020.0246","article-title":"Exosomes: A Tool for Bone Tissue Engineering","volume":"28","author":"Huber","year":"2022","journal-title":"Tissue Eng. Part B Rev."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Cooper, L.F., Ravindran, S., Huang, C.C., and Kang, M. (2019). A Role for Exosomes in Craniofacial Tissue Engineering and Regeneration. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.01569"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Coppin, L., Sokal, E., and St\u00e9phenne, X. (2019). Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives. Cells, 8.","DOI":"10.3390\/cells8101160"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13287-023-03582-3","article-title":"Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem\/stromal cell infusions: Re-evaluating the dogma","volume":"15","author":"Hoang","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kaibuchi, N., Iwata, T., Koga, Y.K., and Okamoto, T. (2022). Novel Cell Therapy Using Mesenchymal Stromal Cell Sheets for Medication-Related Osteonecrosis of the Jaw. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.902349"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/ijms15010605","article-title":"Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-\u03b2\/SMAD2 and PI3K\/Akt pathways","volume":"15","author":"Jun","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/wrr.12398","article-title":"Transforming growth factor beta (TGF-\u03b2) isoforms in wound healing and fibrosis","volume":"24","author":"Lichtman","year":"2016","journal-title":"Wound Repair Regen."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Zelisko, N., Lesyk, R., and Stoika, R. (2024). Structure, unique biological properties, and mechanisms of action of transforming growth factor \u03b2. Bioorg. Chem., 150.","DOI":"10.1016\/j.bioorg.2024.107611"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1563\/aaid-joi-D-21-00035","article-title":"Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series","volume":"49","author":"Otto","year":"2023","journal-title":"J. Oral Implantol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/14712598.2019.1671970","article-title":"Stromal vascular fraction technologies and clinical applications","volume":"19","author":"Andia","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_59","first-page":"455","article-title":"Hematopoietic stem cells local transplantation for the treatment of osteonecrosis of the jaws","volume":"13","author":"Elad","year":"2005","journal-title":"Support Care Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1746-160X-7-16","article-title":"Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw","volume":"7","author":"Cella","year":"2011","journal-title":"Head Face Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10266-017-0295-4","article-title":"Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells","volume":"105","author":"Voss","year":"2017","journal-title":"Odontology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/0284186X.2020.1730004","article-title":"Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: Report of two cases","volume":"59","author":"Orellana","year":"2020","journal-title":"Acta Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jormas.2020.05.024","article-title":"Case reports of medication-related osteonecrosis of the jaw (MRONJ) treated with uncultured stromal vascular fraction and L-PRF","volume":"122","author":"Bouland","year":"2021","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2217\/rme-2019-0081","article-title":"Mesenchymal stem cells modifications for enhanced bone targeting and bone regeneration","volume":"15","author":"Safarova","year":"2020","journal-title":"Regen. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Lau, C.S., Park, S.Y., Ethiraj, L.P., Singh, P., Raj, G., Quek, J., Prasadh, S., Choo, Y., and Goh, B.T. (2024). Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126805"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"23259671211058459","DOI":"10.1177\/23259671211058459","article-title":"High Variability of Mesenchymal Stem Cells Obtained via Bone Marrow Aspirate Concentrate Compared With Traditional Bone Marrow Aspiration Technique","volume":"9","author":"Brozovich","year":"2021","journal-title":"Orthop. J. Sports Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Joo, H.S., Suh, J.H., Lee, H.J., Bang, E.S., and Lee, J.M. (2020). Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030727"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Liu, Y., Liu, H., and Tang, W.H. (2019). Exosomes: Biogenesis, biologic function and clinical potential. Cell Biosci., 9.","DOI":"10.1186\/s13578-019-0282-2"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Raposo","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10142-022-00947-4","article-title":"Non-coding RNAs in human health and disease: Potential function as biomarkers and therapeutic targets","volume":"23","author":"Loganathan","year":"2023","journal-title":"Funct. Integr. Genom."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Hade, M.D., Suire, C.N., and Suo, Z. (2021). Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells, 10.","DOI":"10.3390\/cells10081959"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12964-023-01408-6","article-title":"Protein cargo in extracellular vesicles as the key mediator in the progression of cancer","volume":"22","author":"Balvan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e929684","DOI":"10.12659\/MSM.929684","article-title":"Exosomes from Adipose-Derived Stem Cells Can Prevent Medication-Related Osteonecrosis of the Jaw","volume":"27","author":"Dong","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/0022034520906793","article-title":"Extracellular Vesicles of Stem Cells to Prevent BRONJ","volume":"99","author":"Watanabe","year":"2020","journal-title":"J. Dent. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"12675","DOI":"10.2147\/IJN.S482849","article-title":"Exosomes from Adipose-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw by Inhibiting Macrophage M1 Polarization and Pyroptosis","volume":"19","author":"Zheng","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jcyt.2014.11.009","article-title":"Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration","volume":"17","author":"Kawai","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"117323","DOI":"10.1016\/j.bone.2024.117323","article-title":"Extracellular vesicles from mouse bone marrow macrophages-derived osteoclasts treated with zoledronic acid contain miR-146a-5p and miR-322-3p, which inhibit osteoclast function","volume":"190","author":"Minami","year":"2025","journal-title":"Bone"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Dong, X., Wang, X., Wang, J., Chen, S., He, Y., An, J., He, L., and Zhang, Y. (2023). Exosomes Derived from Adipose Tissue-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw through IL-1RA. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108694"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.2147\/IJN.S305361","article-title":"Small Extracellular Vesicles Derived from Adipose Tissue Prevent Bisphosphonate-Related Osteonecrosis of the Jaw by Promoting Angiogenesis","volume":"16","author":"Huang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.7150\/thno.48291","article-title":"Emerging role of exosomes in craniofacial and dental applications","volume":"10","author":"Xing","year":"2020","journal-title":"Theranostics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1872213X12666180227105924","article-title":"In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells","volume":"12","author":"Chaudhary","year":"2018","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4547875","DOI":"10.1155\/2023\/4547875","article-title":"Comparison of Biological Properties and Clinical Application of Mesenchymal Stem Cells from the Mesoderm and Ectoderm","volume":"2023","author":"Wang","year":"2023","journal-title":"Stem Cells Int."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/4\/595\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:15:59Z","timestamp":1760030159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/4\/595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":82,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["biom15040595"],"URL":"https:\/\/doi.org\/10.3390\/biom15040595","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}